Arch Therapeutics to Present AC5 Advanced Wound System at 2021 Symposium on Advanced Wound Care (SAWC) Fall
October 25, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Launches Experts in Wound Care Program
October 18, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Provides Corporate Update
October 13, 2021 16:30 ET
|
Arch Therapeutics, Inc.
90-Day Report Card for Commercialization Effort FRAMINGHAM, Mass., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of...
Arch Therapeutics to Present at the LD Micro Main Event
October 06, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Launches Coverage and Reimbursement Pilot
October 04, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Announces Appointment of Larry Hicks to the Board
September 30, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Partners with Lovell Government Services to Expand Distribution Capabilities
September 02, 2021 07:00 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), a marketer and developer of novel self-assembling wound care and biosurgical...
Arch Therapeutics Completes Leadership Team with Appointment of Dan Yrigoyen as Vice President of Sales
July 12, 2021 07:50 ET
|
Arch Therapeutics, Inc.
Medical Industry Veteran with Proven Track Record to Drive Commercialization Effort FRAMINGHAM, Mass., July 12, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the...
Arch Therapeutics to Present at the Ladenburg Thalmann 2021 Healthcare Conference, July 13 - 14, 2021
July 07, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., July 07, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...
Arch Therapeutics to Present at the LD Micro Invitational XI, June 8 - 10, 2021
June 02, 2021 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) (“Arch” or the “Company”), developer of novel self-assembling wound care and biosurgical devices, today...